Skip to content

Association Between Age-Dependent DNA Methylation Changes at FKBP5 Enhancer Sites and Increased Cortical Gene Expression in Schizophrenia.

Aug 2026 · American Journal of Psychiatry · pp. appiajp20250473 · 0 citations · 46 references
Medicine

TL;DR

Evidence supports the association of aging and psychiatric diagnosis with changes in FKBP5 DNAm in functionally relevant regulatory elements of the human frontal cortex.

Abstract

Objective

An increasingly compelling body of literature indicates that the glucocorticoid receptor cochaperone FK506-binding protein 51 (FKBP51; encoded by FKBP5) is a promising target for psychiatric therapeutics. Increased mRNA expression of FKBP5 in postmortem brains with psychiatric diagnoses and with aging have been reported previously. The epigenetic mechanisms underlying these effects in the human brain remain largely unknown.

Methods

The authors analyzed previously generated DNA methylation (DNAm) array, single-nucleotide polymorphism genotyping, and bulk RNA-, single-nucleus RNA-, and single-nucleus assay for transposase-accessible chromatin (snATAC)-sequencing data to examine FKBP5 DNAm patterns in postmortem human brain samples from the dorsolateral prefrontal cortex and orbitofrontal cortex of individuals who lived with a major psychiatric disorder (schizophrenia, major depressive disorder, or bipolar disorder) across two independent cohorts (N=378 cases and N=209 controls).

Results

Several cytosine-phosphate-guanine dinucleotides (CpGs) were identified across the proximal enhancer of the FKBP5 locus where DNAm was negatively correlated with gene expression, with validation across both cohorts. Data from single-nucleus analyses supported the relevance of these associations across all major cell types. In this functional region, as well as additional sites, associations were observed with age, rs1360780 genotype (CC versus CT/TT), and psychiatric diagnosis. Notably, individuals with schizophrenia exhibited significantly lower DNAm levels in the proximal enhancer region that showed additional converging effects of age and genotype, specifically in glucocorticoid response element-associated CpG sites.

Conclusions

This evidence supports the association of aging and psychiatric diagnosis with changes in FKBP5 DNAm in functionally relevant regulatory elements of the human frontal cortex. This suggests that related changes in FKBP5 mRNA levels may be mediated by these epigenetic mechanisms.

View source

Similar papers

Open access Oct 2026

Brain DNA methylation, APOE genotype and Alzheimer’s disease neuropathology in a large postmortem cohort

DNA methylation (DNAm) plays a critical role in Alzheimer’s disease (AD). Previous epigenome-wide association studies using 450K arrays captured limited CpG coverage and often focused on a single neuropathological measure. Here we profiled DNAm in 1,250 postmortem prefrontal cortex samples from the Rush Alzheimer’s Dis...

G. Miao, Cheng Gao, Lei Yu et al. · 0 citations
Open access Oct 2026

Brain and cognitive correlates of FKBP5: methylation patterns in schizophrenia.

Schizophrenia (SZ) is a neurodevelopmental disorder influenced by genetic and environmental factors. The stress-related gene FKBP5 shows genetic, epigenetic, and expression variability associated with SZ. Although FKBP5 methylation has been related to brain structural changes in psychiatric conditions, its role in the...

M. Latorre-Guardia, C. Almodóvar-Payá, I. París-Gómez et al. · 0 citations
Aug 2026

Associations between human oxytocin receptor gene promoter DNA methylation and brain structural connectome in panic disorder in Korea.

Lower peripheral OXTR DNAm was associated with higher PD-related symptomatology and altered extended fear network connectivity, suggesting that peripheral OXTR DNAm may index aspects of clinical and neural heterogeneity in PD.

Hyunjung Kim, C. Pae, M. Bang et al. · 0 citations
Sep 2026

Allele-specific expression modulates the immunological and cis-regulatory landscape of Parkinson's Disease.

Results support the view that ASE captures a broad regulatory signature in iPD, distinct from the DNA methylation context, and reinforces the role of immunogenetic dysregulation as a primary component of the disease's pathophysiology, offering new targets for mechanistic investigation and peripheral biomarkers.

R. M. Piergiorge, Alan Tardin da Silva, Ronaldo Francisco et al. · 0 citations
Open access Oct 2026

DNA methylation and proteomic profiling of postmortem brain tissue reveals epigenetic dysregulation and inflammatory signaling in fragile X-associated tremor/ataxia syndrome

Findings identify previously unrecognized DNA methylation alterations in FXTAS prefrontal cortex involving genes related to oxidative stress, myelination, zinc homeostasis, and innate immune/NF-κB signaling.

Reymundo Lozano, Xiao Lin, R. Hagerman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.